The Week

Axon Enterprise fell 7.05% this week to close at $479.34, while the S&P 500 lost 0.8%, leaving the stock about 6.25 percentage points behind the benchmark. The week’s bias was clearly lower. Tuesday (Sep 8) opened at $506.03 and touched $514.615 before easing to $505.43. Wednesday and Thursday slipped further, with Thursday hitting a low of $476.05. Friday (Sep 11) marked the week’s low of $473.25 before finishing at $479.34. Weekly amplitude was 8.17%. Total volume across the four sessions was 3.03 million shares, and the daily average ran about 12.2% below the 60-day median.

Key Events

The week’s news mostly involved institutional position shifts and a fresh read on city ALPR contracts. On Sep 8, Parkside Financial Bank & Trust disclosed the purchase of 19,192 shares. On Sep 11, the Manufacturers Life Insurance Company was reported as a buyer, and the same day CEO Patrick W. Smith sold 10,000 shares worth $5.08 million. On the business side, a Sep 11 report said Axon was reaffirmed as a top pick as cities shift automatic licence-plate-recognition contracts, with a buy rating and an $825 price target maintained. Broader discussions linked the company to the physical build-out of AI and drone-defence themes, but Axon itself released no earnings or major product news during the week.

Analyst Ratings

Among brokers covering Axon, 22 firms have clear views: 8 rate it overweight, 10 buy, 3 hold, and 1 has no opinion, while none rate it underweight or sell. The consensus rating is buy, with a consensus target of $706.21053, roughly 47.33% above the latest price of $479.34. Individual targets range from $440 to $830, a spread of nearly $390 that points to wide disagreement. The stock ranks 10th out of 84 names in the aerospace and defence sector.

The Week Ahead

The macro calendar is busy next week. The New York Fed manufacturing index lands on Tuesday, Sep 15, followed on Wednesday, Sep 16 by retail sales ex-autos, import prices, retail control, the NAHB housing market index, and EIA weekly crude inventories. Axon has no earnings scheduled, so the focus shifts to the pace of ALPR contract awards and whether further insider transactions follow the CEO’s sale. The retail-sales prints matter for risk appetite across high-multiple growth names.

In Short

Axon underperformed the market sharply this week, yet sell-side views remain tilted to the upside: the consensus is buy and the consensus target sits nearly 40% above spot, though the wide target range shows real disagreement on valuation. The latest session’s money flow shows both large and small participants as net sellers, with retail dominating the outflows that accompanied the week’s decline; that snapshot covers only one day and cannot be read as a full-week trend. The key things to watch are the speed of ALPR contract conversions and the macro data’s pull on high-valuation shares.

This article is generated by LongbridgeAI from market data, for information only and not investment advice.